Clinical Trials Browser

SF 1126 × Clear all

NCT02337309 2018-08-20

SF1126 for Patients With Relapsed or Refractory Neuroblastoma

Phase 1 Terminated

Neuroblastoma

NCT02644122 2018-07-11

SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Genes

Phase 2 Terminated

1 enrolled 6 charts

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

NCT00907205 2013-06-13

SF112600106

Phase 1 Completed

Neoplasms